Page last updated: 2024-08-24

arctigenin and gemcitabine

arctigenin has been researched along with gemcitabine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (87.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Abdelhamed, S; Athikomkulchai, S; Awale, S; Miyatake, R; Saiki, I; Ueda, JY; Yokoyama, S1
Abdelhamed, S; Athikomkulchai, S; Awale, S; Dibwe, DF; Miyatake, R; Saiki, I; Ueda, JY; Yokoyama, S1
Awale, S; Shakya, B; Ueda, JY; Yadav, PN1
Awale, S; Do, TN; Esumi, H; Le, TH; Nguyen, HX; Nguyen, MT; Nguyen, NT1
Cui, W; Li, JX; Liu, CX; Shen, Q; Wang, J; Wang, Y; Wu, J; Zhang, L; Zhang, YC1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Saif, MW; Strimpakos, AS1
Esumi, H; Fujioka, R; Ikeda, M; Kishino, S; Mochizuki, N; Nomura, S; Owada, S; Sato, A; Tsuchihara, K; Yomoda, S1

Trials

1 trial(s) available for arctigenin and gemcitabine

ArticleYear
Change in plasma lactate concentration during arctigenin administration in a phase I clinical trial in patients with gemcitabine-refractory pancreatic cancer.
    PloS one, 2018, Volume: 13, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Arctium; Area Under Curve; Biomarkers; Carcinoma, Adenosquamous; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Furans; Gemcitabine; Gluconeogenesis; Humans; Kaplan-Meier Estimate; Kidney; Lactic Acid; Lignans; Liver; Mitochondria; Oxidative Phosphorylation; Pancreatic Neoplasms; Plant Extracts

2018

Other Studies

7 other study(ies) available for arctigenin and gemcitabine

ArticleYear
Antiausterity agents from Uvaria dac and their preferential cytotoxic activity against human pancreatic cancer cell lines in a nutrient-deprived condition.
    Journal of natural products, 2012, Jun-22, Volume: 75, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Bridged-Ring Compounds; Crystallography, X-Ray; Cyclohexenes; Drug Screening Assays, Antitumor; Humans; Nuclear Magnetic Resonance, Biomolecular; Pancreatic Neoplasms; Thailand; Uvaria

2012
Uvaridacols E-H, highly oxygenated antiausterity agents from Uvaria dac.
    Journal of natural products, 2012, Nov-26, Volume: 75, Issue:11

    Topics: Antineoplastic Agents, Phytogenic; Cyclohexenes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pancreatic Neoplasms; Plant Stems; Thailand; Uvaria

2012
Discovery of 2-pyridineformamide thiosemicarbazones as potent antiausterity agents.
    Bioorganic & medicinal chemistry letters, 2014, Jan-15, Volume: 24, Issue:2

    Topics: Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Formamides; Humans; Pancreatic Neoplasms; Pyridines; Thiosemicarbazones

2014
Chemical Constituents of Mangifera indica and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line.
    Journal of natural products, 2016, 08-26, Volume: 79, Issue:8

    Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Mangifera; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pancreatic Neoplasms; Plant Bark; Triterpenes; Vietnam

2016
Synthesis and evaluation of tetrahydroquinolin-2(1H)-one derivatives as novel anti-pancreatic cancer agents via targeting autophagy.
    European journal of medicinal chemistry, 2019, May-15, Volume: 170

    Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Male; Mice, Nude; Pancreas; Pancreatic Neoplasms; Quinolines

2019
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Update on phase I studies in advanced pancreatic adenocarcinoma. Hunting in darkness?
    JOP : Journal of the pancreas, 2013, Jul-10, Volume: 14, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Deoxycytidine; Furans; Gemcitabine; Humans; Hyaluronoglucosaminidase; Lignans; Mutation; Pancreatic Neoplasms; Polyethylene Glycols; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Recombinant Proteins; RNA Interference; Treatment Outcome

2013